针对核糖体来治疗多发性骨髓瘤
Kylee H Maclachlan1,2,3, Kezia Gitareja4,5, Jian Kang4,5
1Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Molecular therapy. Oncology
|April 10, 2024
概括
CX-5461通过抑制核糖体生物生成,有效地向多发性骨髓瘤 (MM) 细胞,显示出对抗蛋白酶体抑制剂耐药癌症的前景. 它与其他药物协同作用,为复发和耐药的MM患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 多发性骨髓瘤 (MM) 细胞具有高的蛋白质合成率,使它们易受蛋白酶体抑制剂 (PI) 的影响.
- 对PI的耐药性是MM治疗中的一个重大临床挑战.
- 一种RNA聚合酶I抑制剂CX-5461在MM患者中显示了初步的抗瘤活性.
研究的目的:
- 评估CX-5461在蛋白质酶抑制剂耐药模型中的抗髓瘤活性.
- 研究CX-5461在多发性骨髓瘤中的作用机制.
- 探索CX-5461与其他抗髓瘤药物的协同作用组合.
主要方法:
- 在体外和体内临床前的PI耐药MM模型 (Vk*MYC和5T33-KaLwRij小鼠模型).
- 评估CX-5461对核糖体生物发生,DNA损伤和细胞循环停止的影响.
- 与蛋白酶体抑制剂和泛基的结合研究.
主要成果:
- 在抗PI耐药的MM模型中,CX-5461表现出强大的抗髓瘤活性.
- CX-5461抑制了核糖体生物发生,诱导DNA损伤,并导致细胞死亡.
- 在体内,CX-5461与帕诺比诺斯塔特有协同作用,但与PI无协同作用.
结论:
- 即使在抗PI的环境中,CX-5461也表现出显著的抗髓瘤活性.
- 向核糖体生物发生是一种可行的策略,用于治疗复发性和耐火性MM.
- 结合CX-5461和泛尼诺斯塔特,需要对MM治疗进行进一步的临床研究.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:24Ribosome Profiling
3.5K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K